Preventing secondary cancer

It’s early days, but Tel Aviv University scientists have managed in lab tests to reduce the incidence of breast cancer relapse by 88%. They used two chemotherapies – doxorubicin and cisplatin together, which reduced the spread of cancer cells (metastasis) that occurred using just one therapy.

https://www.israel21c.org/existing-drug-may-reduce-breast-cancer-relapses-by-88/

https://www.jns.org/israeli-researchers-improve-chemotherapy-treatment-for-breast-cancer-patients/

https://www.nature.com/articles/s41467-022-33598-x

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *